Stockscreener 앱 받기
107.12
1.24%
1.31
전일 마감가:
$105.81
열려 있는:
$105.34
하루 거래량:
3.32M
Relative Volume:
2.29
시가총액:
$21.32B
수익:
$7.60B
순이익/손실:
$1.08B
주가수익비율:
44.45
EPS:
2.41
순현금흐름:
$1.26B
1주 성능:
+0.36%
1개월 성능:
-1.97%
6개월 성능:
+0.82%
1년 성능:
-10.73%
1일 변동 폭
$105.34
$107.78
1주일 범위
$104.47
$110.45
52주 변동 폭
$101.47
$133.90
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
ZBH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
107.12 | 21.32B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Malaysian Reserve
How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Device Stocks? - MSN
Zimmer Biomet receives FDA 510(k) clearance for stemless total shoulder replacement system - Healio
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zimmer Biomet price target raised to $118 from $117 at Truist - Yahoo Finance
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024 - The Eastern Progress Online
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024 - The Malaysian Reserve
Total Wrist Replacement Market Top PlayersZimmer Biomet, - openPR
Zimmer Biomet sets quarterly dividend for Q4 2024 By Investing.com - Investing.com Australia
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet (NYSE:ZBH) Given New $118.00 Price Target at Truist Financial - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Plans Quarterly Dividend of $0.24 - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago - Yahoo Finance
Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend for Fourth Quarter of 2024, Payable on or About January 31, 2025 - Marketscreener.com
Zimmer Biomet sets quarterly dividend for Q4 2024 - Investing.com India
Spine Surgery Devices Market to See Booming Growth 2024-2031 | - openPR
JP Morgan Upgrades Zimmer Biomet Holdings (ZBH) - MSN
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Zimmer Biomet (NYSE:ZBH) Upgraded to "Overweight" at JPMorgan Chase & Co. - MarketBeat
Orthopaedic Implants Market Research with Growth Forecasts - GlobeNewswire
Orthopaedic Implants Market Research with Growth Forecasts to 2029: Industry Dominated by Stryker Corporation, Zimmer Biomet, Johnson & Johnson MedTech, Smith+Nephew, and B. Braun - Yahoo Finance UK
Franklin Resources Inc. Cuts Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
Zimmer receives FDA nod for stemless shoulder implant - Yahoo Finance
Zimmer Biomet’s total shoulder replacement system gains FDA 510(k) clearance - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Purchased by Toronto Dominion Bank - MarketBeat
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, growth targets - Investing.com
MML Investors Services LLC Purchases 19,113 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference - The Eastern Progress Online
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement - BioSpace
Zimmer Biomet wins FDA nod for stemless shoulder system - Mass Device
Zimmer Biomet Secures FDA Clearance for Revolutionary Stemless Shoulder Replacement System - StockTitan
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Virtu Financial LLC - MarketBeat
Geode Capital Management LLC Has $524.94 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Public Employees Retirement System of Ohio - MarketBeat
Verition Fund Management LLC Reduces Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences - The Eastern Progress Online
2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Stifel Financial Corp - MarketBeat
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results - The Eastern Progress Online
Bone Marrow Aspirate Concentrates Industry Report, Featuring Profiles of 45+ Key Players Including Arthrex, Cesca Therapeutics, Globus Medical, Ranfac, Terumo and Zimmer Biomet Holdings - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Average Rating of "Hold" from Analysts - MarketBeat
Why Is Zimmer Biomet Holdings Inc. (ZBH) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? - Yahoo Finance
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
SCOTUS Denies Petition Challenging Post-Patent Expiration Royalty Obligations Upheld in Arbitration - IPWatchdog.com
National Bank of Canada FI Raises Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
High Court Won't Hear Zimmer Biomet Royalties Fight - Law360
XTX Topco Ltd Acquires Shares of 13,851 Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.54%
자본화:
|
볼륨(24시간):